Dsm Capital Partners LLC Astrazeneca PLC Transaction History

Dsm Capital Partners LLC

$5.75 Billion
Q4 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $6,286 - $7,165	103 Added 46.19%	326 $22,000
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $2.46 Million - $2.75 Million	-39,708 Reduced 99.44%	223 $15,000
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $112 Million - $124 Million	-1,729,220 Reduced 97.74%	39,931 $2.7 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $22.3 Million - $24.2 Million	-319,550 Reduced 15.3%	1,769,151 $127 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $8.87 Million - $10.1 Million	-140,386 Reduced 6.3%	2,088,701 $145 Million
Q4 2022 Feb 13, 2023	SELL	$54.21 - $70.44 $2.93 Million - $3.81 Million	-54,088 Reduced 2.37%	2,229,087 $151 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $639,421 - $1.64 Million	-12,060 Reduced 0.53%	2,283,175 $125 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $104 Million - $125 Million	1,756,218 Added 325.82%	2,295,235 $152 Million
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $2.04 Million - $2.46 Million	36,622 Added 7.29%	539,017 $35.8 Million
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $4.74 Million - $5.6 Million	87,775 Added 21.17%	502,395 $29.3 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $2.71 Million - $2.97 Million	48,834 Added 13.35%	414,620 $24.9 Million
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $3.32 Million - $4.13 Million	-68,552 Reduced 15.78%	365,786 $21.9 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $1.72 Million - $1.98 Million	36,412 Added 9.15%	434,338 $21.6 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $15.8 Million - $18.8 Million	324,766 Added 443.91%	397,926 $19.9 Million
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $13,267 - $15,275	250 Added 0.34%	73,160 $4.01 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $3.14 Million - $4.03 Million	72,910 New	72,910 $3.86 Million

Others Institutions Holding AZN

# of Institutions

1,340

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.45 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.97 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.64 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.61 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.35 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $219B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dsm Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dsm Capital Partners LLC with notifications on news.

Account